nvitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SAMSAM ALAMTAJ; Davoodi Sara; Moradi Alamdarloo Shaghayegh; POORDAST TAHEREH; Shiravani Zahra; Morshedzadeh Azade

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Obstetrics, Gynecology and Infertility Year:2021 | Volume:23 | Issue:9 Page(s): 1-7

Download Full-Text

Persian Verion

View:

381

Download:

Cites:

Information Journal Paper

Title

nvitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg

Author(s)

Keywords

Gonadotropin-releasing antagonistQ1

Human placental gonadotropinQ2

In vitro fertilizationQ1

Ovulation stimulationQ2

Abstract

Introduction: Human chorionic gonadotropin for the final maturation of eggs in the In-vitro fertilization cycle was associated with the possibility of a negative effect on endometrial acceptance, fetal quality and ovarian hyper stimulation syndrome. Replacing it with a gonadotropin-releasing hormone agonist to trigger final ovulation is expected to reduce these effects. Therefore, this study was performed with aim to evaluate the outcome of triggering in In vitro fertilization with antagonist protocol by gonadotropin-releasing hormone agonist, human chorionic gonadotropin simultaneously with human gonadotropin-releasing hormone agonist and human chorionic gonadotropin. Methods: In this randomized clinical trial study conducted in 2015 and 2016, women were divided into three random groups after preparing the follicles for triggering and ovum retrieval. One group received 0. 2 mg of dipherline, the second group received 10, 000 units of human chorionic gonadotropin and the other group received 0. 2 mg of dipherline along with 1500 units of human chorionic gonadotropin. The number and quality of eggs and embryos were the outcomes of the study. Data were analyzed by SPSS software (version 17) and Leven tests and one-way analysis of variance. P < 0. 05 was considered statistically significant. Results: The number of retrieved oocytes in the group receiving gonadotropin-releasing agonist was significantly higher than the other groups (p = 0. 001). More embryos were produced in the gonadotropin-releasing hormone agonist group compared to the other two groups (p = 0. 009). However, the number of high quality embryos produced in the groups was similar. Conclusion: The onset of final oocyte maturation with gonadotropin-releasing hormone agonist significantly increases the number of retrieved oocytes and obtained embryos. However, dual stimulation using low-dose human chorionic gonadotropin (IU1500) and gonadotropin-releasing hormone agonist did not alter quality of embryo compared to the standard dose of human chorionic gonadotropin (IU10000).

Cites

No record.

References

No record.

Cite

APA: Copy

SAMSAM, ALAMTAJ, Davoodi, Sara, Moradi Alamdarloo, Shaghayegh, POORDAST, TAHEREH, Shiravani, Zahra, & Morshedzadeh, Azade. (2021). nvitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg. IRANIAN JOURNAL OF OBSTETRICS, GYNECOLOGY AND INFERTILITY, 23(9 ), 1-7. SID. https://sid.ir/paper/400859/en

Vancouver: Copy

SAMSAM ALAMTAJ, Davoodi Sara, Moradi Alamdarloo Shaghayegh, POORDAST TAHEREH, Shiravani Zahra, Morshedzadeh Azade. nvitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg. IRANIAN JOURNAL OF OBSTETRICS, GYNECOLOGY AND INFERTILITY[Internet]. 2021;23(9 ):1-7. Available from: https://sid.ir/paper/400859/en

IEEE: Copy

ALAMTAJ SAMSAM, Sara Davoodi, Shaghayegh Moradi Alamdarloo, TAHEREH POORDAST, Zahra Shiravani, and Azade Morshedzadeh, “nvitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg,” IRANIAN JOURNAL OF OBSTETRICS, GYNECOLOGY AND INFERTILITY, vol. 23, no. 9 , pp. 1–7, 2021, [Online]. Available: https://sid.ir/paper/400859/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops